Simplicity Wealth’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
+3,419
New +$177K 0.01% 918
2024
Q3
Sell
-4,838
Closed -$575K 934
2024
Q2
$575K Buy
4,838
+1,161
+32% +$147K 0.01% 700
2024
Q1
$392K Buy
+3,677
New +$371K 0.01% 822

Other funds holding MRNA

Simplicity Wealth's MRNA Position: Q2 2026 in Review

Simplicity Wealth opened a new position in Moderna (MRNA) in Q2 2026: 3,419 shares worth $239K. The stake represents 0.01% of the portfolio and ranks #918 among its holdings. This is a return to the name: Simplicity Wealth previously reported a position in MRNA as recently as Q2 2024.

Simplicity Wealth first reported a position in MRNA in Q1 2024 and has held it in 3 quarters since. The position peaked at $575K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Simplicity Wealth held 3,419 shares of Moderna worth $239K as of Q2 2026.
  • Moderna was a new Simplicity Wealth position in Q2 2026.
  • Moderna made up 0.01% of Simplicity Wealth's portfolio in Q2 2026, its #918 holding.
  • Simplicity Wealth first reported a position in Moderna in Q1 2024 and has held it in 3 quarters since.
  • Simplicity Wealth's Moderna position peaked at $575K in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.